Vaxcyte Inc expected to post a loss of 84 cents a share - Earnings Preview

Vaxcyte

03/11/2023 11:40

* Vaxcyte Inc  PCVX.OQ   PCVX.O  is expected to show no
change in
quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Vaxcyte Inc is for
a loss
of 84 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxcyte Inc
is
$68​, above​ its last closing price of $47.80. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.75       -0.74      -0.70     Beat    6
 Mar. 31 2023  -0.84       -0.83      -0.70     Beat    15.2
 Dec. 31 2022  -0.98       -0.93      -1.02     Missed  -9.7​
 Sep. 30 2022  -0.84       -0.84      -0.93     Missed  -11.2
 ​​Jun.        -0.69       -0.69      -0.80     Missed  -15.9
 30 2022                                                
 Mar. 31 2022  -0.64       -0.63      -0.68     Missed  -8.5​
 Dec. 31 2021  -0.52       -0.56      -0.55     Beat    1.8
 Sep. 30 2021  -0.53       -0.55      -0.51     Beat    6.7
 This summary was machine generated November 3 at 11:40 GMT.  All
figures in US dollars  unless otherwise stated